For the first time to our knowledge, we were able to cross-compare in an omics-wide manner the prognostication powers of quantitative levels of CD20 protein, CD20 mRNA (MS4A1), and TIL-B in pan-cancers using highly quantitative proteomics from TCPA and transcriptomic data from TCGA. Here, MS4A1 is linked to cancer.